Skip to main content
. 2015 Mar 24;6(6):632–639. doi: 10.1111/jdi.12341

Table 1.

Clinical characteristics of study participants

Clinical characteristics Type 2 diabetes Non-diabetic controls P-value
n (male/female) 202 (58/144) 188 (53/135)
Age (years) 53.75 ± 11.00 53.34 ± 9.09 NS
Age at diagnosis (years) 49.39 ± 10.87 ND ND
Weight (kg) 68.57 ± 12.46 59.25 ± 9.89 <0.001
BMI (kg/m2) 27.84 ± 4.95 23.91 ± 3.17 <0.001
Waist circumference (cm) 87.99 ± 10.90 82.21 ± 9.37 <0.001
Hip circumference (cm) 99.82 ± 9.73 95.62 ± 6.69 <0.001
Waist-to-hip ratio 0.89 ± 0.07 0.86 ± 0.06 <0.001
Systolic BP (mmHg) 132.13 ± 16.16 116.14 ± 15.12 <0.001
Diastolic BP (mmHg) 81.42 ± 10.40 70.31 ± 9.90 <0.001
Fasting glucose (mmol/L) 11.34 ± 5.09 4.88 ± 0.35 <0.001
HbA1c (%) 8.34 ± 2.58 5.36 ± 0.26 <0.001
Total cholesterol (mmol/L) 5.86 ± 1.19 5.32 ± 0.93 <0.001
Triglyceride (mmol/L) 4.63 ± 2.33 2.68 ± 1.11 <0.001
LDL (mmol/L) 3.70 ± 1.08 3.23 ± 0.86 <0.001
HDL (mmol/L) 1.27 ± 0.31 1.58 ± 0.42 <0.001

Data are shown as mean ± standard deviation. P-values compare clinical and laboratory data between 202 type 2 diabetes patients and 188 non-diabetic controls with completely available data, using either Mann–Whitney U-test or Student's unpaired t-test. BMI, body mass index; BP, blood pressure; HbA1c, glycated hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ND, not determined; NS, not significant.